Nuveen’s BioTelemetry, Inc. BEAT Stock Holding History

Nuveen’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-133,977	Closed	-$9.66M	–	3437
2020 Q4	$9.66M	Sell	133,977 -1,612	-1%	-$84.4K	﹤0.01%	1730
2020 Q3	$6.18M	Sell	135,589 -33,517	-20%	-$1.4M	﹤0.01%	1806
2020 Q2	$7.64M	Sell	169,106 -28,263	-14%	-$1.27M	﹤0.01%	1672
2020 Q1	$7.6M	Buy	197,369 +3,607	+2%	+$166K	﹤0.01%	1462
2019 Q4	$8.97M	Sell	193,762 -768	-0.4%	-$33.3K	﹤0.01%	1650
2019 Q3	$7.92M	Buy	194,530 +3,488	+2%	+$151K	﹤0.01%	1703
2019 Q2	$9.2M	Buy	+191,042	New	+$10M	﹤0.01%	1656

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Nuveen's BEAT Position: Q1 2021 in Review

Nuveen sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 133,977 shares — an estimated $9.66M sold.

Nuveen first reported a position in BEAT in Q2 2019 and held it in 7 quarters. The position peaked at $9.66M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Nuveen reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Nuveen sold 133,977 BioTelemetry, Inc. shares in Q1 2021, an estimated $9.66M.
Nuveen first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 7 quarters.
Nuveen's BioTelemetry, Inc. position peaked at $9.66M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.